344 results on '"Miller, Robert S."'
Search Results
2. Reaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies
3. Association of treatment-emergent symptoms identified by patient-reported outcomes with adjuvant endocrine therapy discontinuation
4. Cancer Registry Data Linkage of Electronic Health Record Data From ASCOʼs CancerLinQ: Evaluation of Advantages, Limitations, and Lessons Learned
5. Chasm Between Cancer Quality Measures and Electronic Health Record Data Quality
6. Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies
7. Summary of the 12 Most Common Cancers in the CancerLinQ Discovery (CLQD) Database
8. Reply to J. Chen et al
9. Health Data Sharing Perspectives of Patients Receiving Care in CancerLinQ-Participating Oncology Practices
10. Real‐world Big‐data: Strengths and weaknesses of ASCO 's CancerLinQ ® discovery multiple myeloma dataset
11. Data from The Effects of a Remote-based Weight Loss Program on Adipocytokines, Metabolic Markers, and Telomere Length in Breast Cancer Survivors: the POWER-Remote Trial
12. Table A1: ICD-9-CM Neoplasm Terms for Lung Cancer from Impact of Broadening Trial Eligibility Criteria for Patients with Advanced Non–Small Cell Lung Cancer: Real-World Analysis of Select ASCO-Friends Recommendations
13. Supplemental Figure 2 from The Effects of a Remote-based Weight Loss Program on Adipocytokines, Metabolic Markers, and Telomere Length in Breast Cancer Survivors: the POWER-Remote Trial
14. Supplemental Legend from The Effects of a Remote-based Weight Loss Program on Adipocytokines, Metabolic Markers, and Telomere Length in Breast Cancer Survivors: the POWER-Remote Trial
15. Supplemental Table 1 from The Effects of a Remote-based Weight Loss Program on Adipocytokines, Metabolic Markers, and Telomere Length in Breast Cancer Survivors: the POWER-Remote Trial
16. Supplemental Figure 1 from The Effects of a Remote-based Weight Loss Program on Adipocytokines, Metabolic Markers, and Telomere Length in Breast Cancer Survivors: the POWER-Remote Trial
17. Case Studies for Overcoming Challenges in Using Big Data in Cancer
18. Challenges to Using Big Data in Cancer
19. Cutaneous Leishmaniasis following Local Trauma: A Clinical Pearl
20. Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 and Subsequent Mortality in a Multisite Cohort of Patients With Cancer in the CancerLinQ Discovery Database
21. Creating a Learning Health Care System in Oncology
22. Quantitating and assessing interoperability between electronic health records
23. Adhesives for Building Construction
24. Digital symptom monitoring with patient-reported outcomes in community oncology practices: A U.S. national cluster randomized trial.
25. Challenges and opportunities to developing a frailty index using electronic health record data
26. Human Leukocyte Interferon: Production, Purification to Homogeneity, and Initial Characterization
27. Lipogenesis and the Synthesis and Secretion of Very Low Density Lipoprotein by Avian Liver Cells in Nonproliferating Monolayer Culture. Hormonal Effects
28. Impressions of Dissenters and Conformers: An Attributional Analysis
29. The Effects of Being Imitated on Children's Responses in a Marble-Dropping Task
30. Synthetic Polynucleotides and the Amino Acid Code, VI
31. Synthetic Polynucleotides and the Amino Acid Code, VII
32. Synthetic Polynucleotides and the Amino Acid Code, VIII
33. Synthetic Polynucleotides and the Amino Acid Code, IX
34. Updated Results of TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathological Complete Response to Pertuzumab and Trastuzumab in Breast Cancer
35. From the Editor's Desk: SDWA Asks Water Providers to Do Impossible
36. Real‐world Big‐data: Strengths and weaknesses of ASCO's CancerLinQ® discovery multiple myeloma dataset.
37. Understanding the Factors That Influence the Adoption and Meaningful Use of Social Media by Physicians to Share Medical Information
38. Efficacy of supplemented buffered peptone water for the isolation of Campylobacter jejuni and C. coli from broiler retail products
39. Drug sensitivity of Plasmodium falciparum along the Thai–Myanmar border using the new field-deployable HRP2 in vitro assay
40. Identification of Transgender People With Cancer in Electronic Health Records: Recommendations Based on CancerLinQ Observations
41. Abstract PS7-66: Real-world clinical outcomes of patients with BRCA-mutated (BRCAm) HER2-negative metastatic breast cancer: A CancerLinQ® study
42. Impact of Broadening Trial Eligibility Criteria for Patients with Advanced Non–Small Cell Lung Cancer: Real-World Analysis of Select ASCO-Friends Recommendations
43. Evaluation of agar plates for direct enumeration of Campylobacter spp. from poultry carcass rinses
44. Speech discrimination after early exposure to pulsed-noise or speech
45. Development of CancerLinQ, a Health Information Learning Platform From Multiple Electronic Health Record Systems to Support Improved Quality of Care
46. Improving Cancer Data Interoperability: The Promise of the Minimal Common Oncology Data Elements (mCODE) Initiative
47. Disproportionate impact of COVID-19 disease among racial and ethnic minorities in the U.S. cancer population as seen in CancerLinQ Discovery data.
48. Impact of curated data on electronic quality measure capture rates within CancerLinQ.
49. Recommendations for patient similarity classes: results of the AMIA 2019 workshop on defining patient similarity
50. The Effects of a Remote-based Weight Loss Program on Adipocytokines, Metabolic Markers, and Telomere Length in Breast Cancer Survivors: the POWER-Remote Trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.